These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9923924)

  • 1. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
    Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
    Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
    Conner JR; Hornick JL
    Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
    Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant fibrous histiocytoma of bone and osteosarcoma. A comparative light and electron microscopic study.
    Roessner A; Hobik HP; Grundmann E
    Pathol Res Pract; 1979 Aug; 164(4):385-401. PubMed ID: 229475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary giant-cell-rich osteosarcoma of the urinary bladder: usefulness of osteocalcin and osteonectin immunohistochemical staining and literature review.
    Won KY; Lee CH; Kim YW; Park YK
    Pathology; 2011 Feb; 43(2):161-4. PubMed ID: 21233679
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Moosavi C; Jha P; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors.
    O'Connell JX; Wehrli BM; Nielsen GP; Rosenberg AE
    Am J Surg Pathol; 2000 Mar; 24(3):386-95. PubMed ID: 10716152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone matrix production in osteosarcoma].
    Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
    Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: a clinicopathologic review and immunohistochemical study of c-fos, c-jun, type I collagen, osteonectin, osteopontin, and osteocalcin.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 1999 Dec; 30(12):1418-26. PubMed ID: 10667418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
    Park YK; Yang MH; Kim YW; Park HR
    J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
    Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
    J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
    Jiang L; Liu J; Wei Q; Wang Y
    Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases.
    Lidang Jensen M; Schumacher B; Myhre Jensen O; Steen Nielsen O; Keller J
    Am J Surg Pathol; 1998 May; 22(5):588-94. PubMed ID: 9591729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases.
    Bane BL; Evans HL; Ro JY; Carrasco CH; Grignon DJ; Benjamin RS; Ayala AG
    Cancer; 1990 Jun; 65(12):2762-70. PubMed ID: 2160317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.